期刊文献+

MicroRNA在多囊卵巢综合征中的表达及作用 被引量:6

Expression and Effect of MicroRNA in Patients with Polycystic Ovary Syndrome
下载PDF
导出
摘要 非编码微小RNAs(microRNAs,miRNAs)主要在转录后水平上调控基因表达,异常miRNA表达与胰岛素抵抗、糖尿病、炎症及各种癌症形成有关。多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者血清及卵泡液中miRNAs表达谱存在差异,其异常的miRNAs表达能够通过影响基因转录后水平,参与PCOS的发生发展。综述miR-93、miR-222、miR-92a/b、miR-224、miR-320、miR-9、miR-483-5p、miR-513a-3p、miR-24、miR-133b、miR-26b和miR-378在PCOS患者的胰岛素抵抗、性激素合成和分泌、颗粒细胞增生、卵泡发育异常及排卵障碍中的作用,探讨miRNA在PCOS发病机制中的作用。 Non-coding microRNAs(microRNAs,miRNAs) are able to regulate the expression of target genes at the post-transcriptional level. Altered miRNA levels are associated with the pathological development of diabetes,insulin resistance,inflammation and various cancers. The miRNAs profiles express differently in the serum and follicular fluid of women with polycystic ovary syndrome(PCOS). Altered miRNA levels may participate in the development of PCOS. Here,we summarize the effects of miR-93,miR-222,miR-92a/b,miR-224,miR-320,miR-9,miR-483-5p,miR-513a-3p,miR-24,miR-133 b,miR-26 b and miR-378 in insulin resistance,steroid hormone synthesis and secretion,granule cell proliferation,follicular development dysplasia and ovulation disorder in PCOS patients,so as to explore the roles of miRNAs in the pathogenesis of PCOS.
出处 《国际生殖健康/计划生育杂志》 CAS 2016年第2期146-150,共5页 Journal of International Reproductive Health/Family Planning
基金 上海市卫生和计划生育委员会科研基金面上项目(201540214)
关键词 微RNAS 多囊卵巢综合征 胰岛素抗药性 性腺甾类激素 MicroRNAs Polycystic ovary syndrome Insulin resistance Gonadal steroid hormones
  • 相关文献

参考文献1

二级参考文献36

  • 1Diamanti-Kandarakis E. Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 2008; lO:e3.
  • 2Diamanti-Kandarakis E. Insulin resistance in PCDS. Endocrine 2006;30: 13-7.
  • 3Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 1997; 18:774-800.
  • 4Ho CK, Wood JR, Stewart DR, Ewens K, Ankener W, Wickenheisser J, et al. Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 2005;90:6596-602.
  • 5Li M, Youngren JF, Dunaif A, Goldfine lD, Maddux BA, Zhang BB, et al. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCDS: Effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 2002;87:4088-93.
  • 6Corbould A, Dunaif A. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism 2007;56:716-22.
  • 7Manneras-Holm L, Leonhardt H, Kullberg J, Jennische E, Oden A, Holm G, et al, Adipose tissue has aberrant morphology and function in PCDS: Enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 2011 ;96:E304-11.
  • 8Peppa M, Koliaki C, Nikolopoulos P, Raptis SA. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol 2010;2010:527850.
  • 9Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001 ;52:401-19.
  • 10Carletti MZ, Christenson LK. MicroRNA in the ovary and female reproductive tract. J Anim Sci 2009;87:E29-38.

共引文献14

同被引文献45

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部